Blog
RSS FeedPosted by Michael Wonder on 25 Mar 2019
Melbourne's Peter MacCallum Cancer Centre to be home of 'the next great wave in treatment'
25 March 2019 - A new form of cancer treatment that uses cell therapy to attack the disease will become ...
Posted by Michael Wonder on 17 Mar 2019
Prescription drug prices are out of control
17 March 2019 - In an all-too-rare example of political consensus, congressional law makers on both sides of the aisle ...
Posted by Michael Wonder on 17 Mar 2019
What 1 April 2019 private health insurance changes mean for you
17 March 2019 - When the calendar flips to April 1 this year, many private health insurance customers will need ...
Posted by Michael Wonder on 17 Mar 2019
Toward a strategy to involve patients in health technology assessment in Spain
14 March 2019 - The aim of this study was to develop a feasible and effective strategy to involve patients in ...
Posted by Michael Wonder on 17 Mar 2019
On the use of list prices in drug pricing research
14 March 2019 - In the limitations section of this article, we discussed in detail that list prices do not capture ...
Posted by Michael Wonder on 17 Mar 2019
'Have you got insurance?': the US style question finding its way to Australian hospitals
16 March 2019 - “Have you got insurance?” It is the first question faced by any patient walking into a ...
Posted by Michael Wonder on 17 Mar 2019
Statement from FDA Commissioner and Director of the Center for Devices and Radiological Health on efforts to evaluate materials in medical devices to address potential safety questions
15 March 2019 - We’re in an unprecedented era of innovation in medical devices with advances in materials science that ...
Posted by Michael Wonder on 16 Mar 2019
Women with advanced breast cancer ask the PM to intervene
15 March 2019 - On Wednesday 13 March, ten women with advanced breast cancer presented to the Health Select Committee to ...
Posted by Michael Wonder on 16 Mar 2019
Obama 'missed opportunity' to address drug costs in Obamacare
15 March 2019 - Democratic presidential candidate Sen. Amy Klobuchar said not doing more to address prescription drug prices in ...
Posted by Michael Wonder on 16 Mar 2019
European Commission approves Roche’s MabThera (rituximab) for a rare auto-immune disease
15 March 2019 - MabThera is now approved in Europe to treat four auto-immune diseases. ...
Posted by Michael Wonder on 16 Mar 2019
Institute for Clinical and Economic Review publishes revised protocol for assessing unsupported price increases for prescription drugs
15 March 2019 - Through April 19, ICER is accepting public input on which additional price increases should be included ...
Posted by Michael Wonder on 15 Mar 2019
Spectrum Pharmaceuticals provides BLA filing update for Rolontis (eflapegrastim)
15 March 2019 - Spectrum Pharmaceuticals announced today that due to the U.S. FDA's request for additional manufacturing-related information for ...
Posted by Michael Wonder on 15 Mar 2019
PBAC Public Summary Documents - November 2018 meeting (rejections and deferrals)
15 March 2019 - The Public Summary Documents (first time rejections and deferrals) from the November 2018 PBAC meeting are now ...
Posted by Michael Wonder on 15 Mar 2019
Health Canada begins release of clinical data on drugs and devices
14 March 2019 - Health Canada launched two public databases on Wednesday as the first step in making clinical information ...
Posted by Michael Wonder on 15 Mar 2019
Eton Pharmaceuticals submits new drug application for DS-200
14 March 2019 - FDA previously granted DS-200 fast track designation. ...
Posted by Michael Wonder on 15 Mar 2019
Karyopharm announces FDA extension of review period for selinexor new drug application
14 March 2019 - PDUFA action date extended by three months to July 6, 2019. ...